Cobblestone Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$736K Sell
12,772
-2,174
-15% -$125K 0.31% 46
2026
Q1
$906K Sell
14,946
-6,526
-30% -$380K 0.41% 42
2025
Q4
$1.16M Sell
21,472
-1,216
-5% -$58.5K 0.52% 36
2025
Q3
$1.02M Sell
22,688
-1,193
-5% -$55.7K 0.47% 37
2025
Q2
$1.11M Buy
23,881
+15
+0.1% +$736 0.58% 33
2025
Q1
$1.46M Hold
23,866
0.85% 28
2024
Q4
$1.35M Hold
23,866
0.88% 25
2024
Q3
$1.23M Hold
23,866
0.74% 22
2024
Q2
$991K Sell
23,866
-100
-0.4% -$4.47K 0.64% 24
2024
Q1
$1.3M Buy
23,966
+100
+0.4% +$5.09K 0.88% 19
2023
Q4
$1.22M Buy
23,866
+11,644
+95% +$611K 0.9% 17
2023
Q3
$709K Buy
+12,222
New +$749K 0.58% 30

Other funds holding BMY

Cobblestone Asset Management's BMY Position: Q2 2026 in Review

Cobblestone Asset Management reduced its Bristol-Myers Squibb (BMY) stake by 15% in Q2 2026, selling an estimated $125K and leaving 12,772 shares worth $736K. The position accounts for 0.31% of the portfolio, ranked #46.

Cobblestone Asset Management first reported a position in BMY in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.46M in Q1 2025. 936 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Cobblestone Asset Management held 12,772 shares of Bristol-Myers Squibb worth $736K as of Q2 2026.
  • Cobblestone Asset Management sold 2,174 Bristol-Myers Squibb shares in Q2 2026, an estimated $125K.
  • Bristol-Myers Squibb made up 0.31% of Cobblestone Asset Management's portfolio in Q2 2026, its #46 holding.
  • Cobblestone Asset Management first reported a position in Bristol-Myers Squibb in Q3 2023 and has held it in 12 quarters since.
  • Cobblestone Asset Management's Bristol-Myers Squibb position peaked at $1.46M in Q1 2025.
  • 936 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Cobblestone Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.